|Articles|January 1, 2019
- Applied Clinical Trials-01-01-2019
- Volume 28
- Issue 1
Applied Clinical Trials, January/February 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials January/February 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
EMA Seeks Input on its Regulatory Science Strategyover 7 years ago
Q&A: Capitalizing on Technology-Enabled Clinical Researchover 7 years ago
The Case for Thinking Outside the HR Boxover 7 years ago
Five Trends in Clinical Trials We’ll See in 2019over 7 years ago
FDA Sets Goals for Improvement in Drug Development and Approvalover 7 years ago
Can Data from EHR Systems Be Trusted in a Trial Setting?over 7 years ago
Weighing the Benefits of RBM Implementationover 7 years ago
Analytics and Metrics Help Pinpoint Costs of Study Start-UpAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5